Could probiotics shield ICU patients from deadly infections?
NCT ID NCT07164781
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 35 times
Summary
This study tests whether giving probiotics (Bacillus clausii) to critically ill adults can reduce infections like pneumonia, bloodstream infections, and UTIs. One hundred ICU patients will receive either the probiotic or a sugar pill. The main goal is to see if probiotics lower the number of systemic infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Benha University Hospitals
Banhā, Qalyubia Governorate, 13518, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bacillus clausii (a type of probiotic)
What this could lead to
If it works, this could point toward a simple, low-cost way to lower infection rates in intensive care patients.
What could go wrong
This is a small, early-stage trial (100 patients) with no phase designation. Probiotics may not prevent infections, and results may not apply to all ICU patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.